CD101
protein-codingCD101 molecule, the group of I-set domain containing|V-set domain containing|CD molecules
Gene summary
Predicted to enable hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides. Predicted to be involved in cell surface receptor signaling pathway. Predicted to act upstream of or within several processes, including T cell homeostasis; positive regulation of myeloid leukocyte differentiation; and response to insulin. Located in extracellular exosome. [provided by Alliance of Genome Resources, Jun 2026]
- IGSF2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~34.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CD101 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001256106.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 4 | 2 | 8 | ||
| missense | 121 | 11 | 5 | 137 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | ||||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 0 | 0 | 127 | 15 | 7 | 149 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001243035.1 | 9 | MANE Select | |
| Ensembl | ENSP00000508039.1 | 9 | MANE Select | |
| RefSeq | NP_001243038.1 | 9 | Standard | |
| RefSeq | NP_001243040.1 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Generation of second messenger molecules
- TCR signaling
- Immune System
- Adaptive Immune System
Biological Process
- positive regulation of myeloid leukocyte differentiation
- cell surface receptor signaling pathway
Molecular Function
- hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides
Cellular Component
- plasma membrane
- integral component of membrane
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000256652
- Coding exons
- 9
- Length
- 34786
- Individuals with no LoFs
- 125450
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 298
- Defined
- 125748
- p
- 0.00119
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.360 | 528 | 552 | 0.957 | 0.0000291 | 6644 |
| Missense (PolyPhen) | 117 | 131.43 | 0.89022 | 1657 | ||
| Synonymous | 0.292 | 217 | 223 | 0.975 | 0.0000124 | 2022 |
| Loss of Function | 2.35 | 27 | 43.8 | 0.616 | 0.00000202 | 518 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00080 | 0.00080 | rare |
| Latino/Admixed American | 0.0016 | 0.0016 | notable |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.0013 | 0.0013 | notable |
| Finnish | 0.0034 | 0.0034 | notable |
| European (Non-Finnish) | 0.00094 | 0.00093 | rare |
| South Asian | 0.00039 | 0.00039 | rare |
| Other | 0.0023 | 0.0023 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plays a role as inhibitor of T-cells proliferation induced by CD3. Inhibits expression of IL2RA on activated T-cells and secretion of IL2. Inhibits tyrosine kinases that are required for IL2 production and cellular proliferation. Inhibits phospholipase C-gamma-1/PLCG1 phosphorylation and subsequent CD3- induced changes in intracellular free calcium. Prevents nuclear translocation of nuclear factor of activated T-cell to the nucleus. Plays a role in the inhibition of T-cell proliferation via IL10 secretion by cutaneous dendritic cells. May be a marker of CD4(+) CD56(+) leukemic tumor cells. {ECO:0000269|PubMed:11093127, ECO:0000269|PubMed:15737213, ECO:0000269|PubMed:7722299, ECO:0000269|PubMed:9233604, ECO:0000269|PubMed:9389317, ECO:0000269|PubMed:9647226}.;
Recessive Scores
- pRec
- 0.162
Intolerance Scores
- LoFtool
- 0.624
- RVIS EVS
- 1.68
- RVIS percentile EVS
- 96.34
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.539
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |